Delivery Order SPE2DB22D2218-SPE2DB25FR3CM
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,452.56 for 1,000 tablets of Januvia 100 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is a firm fixed price, non-set-aside delivery order issued by the Defense Department's Medical Supply Chain organization. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply delivery under the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,091.46 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Januvia 100 mg tablets (90-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $20,394.12 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count packages) valued at $2,678.60. This is a firm fixed-price delivery order with a completion date of July 25, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $6,948 by the Defense Logistics Agency (DLA) Troop Support Medical. The order is to supply 90 tablets of Januvia 100 mg to support pharmaceutical needs under DLA medical programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 13, 2023. As a leading pharmaceutical distributor, Amerisourcebergen holds indefinite delivery contracts...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order operates...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Januvia 100 mg tablets in a quantity of 90 units, with a contract value of $2,182.92. The award utilizes firm fixed pricing with no set-aside designation, indicating competitive selection. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $15,238.68 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of July 24, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The award was processed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3CMDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $40,455.90 by the Defense Logistics Agency (DLA) for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of August 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support Defense Health Agency operations and other government healthcare systems. The Januvia delivery represents a routine pharmaceutical procurement typical of the company's extensive contract portfolio with DLA, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition and its established position as a pharmaceutical prime vendor underscore its role in supporting military healthcare supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.5k | 8/7/25 |